Medtronic Cash Dividends, Common Stock increased by 1.4% to $910.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.3%, from $898.00M to $910.00M. Over 4 years (FY 2021 to FY 2025), Cash Dividends, Common Stock shows an upward trend with a 3.6% CAGR.
tmo_cash_dividends_common_stock| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $781.00M | $846.00M | $961.00M | $733.00M | $843.00M | $903.00M | $933.00M | $875.00M | $905.00M | $918.00M | $877.00M | $958.00M | $913.00M | $898.00M | $922.00M | $872.00M | $897.00M | $910.00M |
| QoQ Change | — | +8.3% | +13.6% | -23.7% | +15.0% | +7.1% | +3.3% | -6.2% | +3.4% | +1.4% | -4.5% | +9.2% | -4.7% | -1.6% | +2.7% | -5.4% | +2.9% | +1.4% |
| YoY Change | — | — | — | — | +7.9% | +6.7% | -2.9% | +19.4% | +7.4% | +1.7% | -6.0% | +9.5% | +0.9% | -2.2% | +5.1% | -9.0% | -1.8% | +1.3% |